Register for our free email digests:
Latest From Schwarz Pharma AG
UCB has chosen Daiichi Sankyo as its new commercial partner in Japan for an epilepsy drug, building on an existing relationship in the allergy area.
The United Arab Emirates ordered a recall of Germany-based Schwarz Pharma's Nitrocine (glyceryl trinitrate) for treating heart and blood-pressure problems on grounds it may contain impurities.
The required divestitures are quite significant relative to the size of the transaction: this is the second-largest divesture, but only the fifth-largest merger of generic firms.
- Therapeutic Areas
- Infectious & Viral Diseases
- North America
- Parent & Subsidiaries
- Cel-Sci Corp.
- Senior Management
Geert R Kersten, CEO
Eyal Talor, PhD, CSO
Todd S Burkhart, VP, Mfg./Facilities & Commercial Ops.
- Contact Info
Phone: (703) 506-9460
8229 Boone Blvd.
Vienna, VA 22182
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.